Aoki M - Search Results

1

Oral consumption of α-glucosyl-hesperidin could prevent lens hardening, which causes presbyopia.

Nakazawa Y, Aoki M, Doki Y, Morishita N, Endo S, Nagai N, Funakoshi-Tago M, Tamura H. Nakazawa Y, et al. Among authors: aoki m. Biochem Biophys Rep. 2020 Dec 26;25:100885. doi: 10.1016/j.bbrep.2020.100885. eCollection 2021 Mar. Biochem Biophys Rep. 2020. PMID: 33392397 Free PMC article.

2

Oral intake of α‑glucosyl‑hesperidin ameliorates selenite‑induced cataract formation.

Nakazawa Y, Aoki M, Ishiwa S, Morishita N, Endo S, Nagai N, Yamamoto N, Funakoshi-Tago M, Tamura H. Nakazawa Y, et al. Among authors: aoki m. Mol Med Rep. 2020 Mar;21(3):1258-1266. doi: 10.3892/mmr.2020.10941. Epub 2020 Jan 14. Mol Med Rep. 2020. PMID: 32016451 Free PMC article.

3

Reduced histone H3K4 trimethylation in oral mucosa of patients with DYT-KMT2B.

Sugeno N, Kumada S, Kashii H, Ikezawa J, Kawarai T, Nakamura T, Miyata A, Ishiyama S, Sato K, Yoshida S, Sekiguchi H, Hamanaka K, Miyatake S, Miyake N, Matsumoto N, Akagawa H, Kosaki K, Yoshihashi H, Hasegawa T, Aoki M. Sugeno N, et al. Parkinsonism Relat Disord. 2024 May 27;124:107018. doi: 10.1016/j.parkreldis.2024.107018. Online ahead of print. Parkinsonism Relat Disord. 2024. PMID: 38810319

4

Prognostic significance of preoperative to postoperative serum carcinoembryonic antigen ratio after lobectomy for lung adenocarcinoma.

Kamimura G, Aoki M, Iwamoto M, Tsuneyoshi Y, Morizono S, Umehara T, Harada-Takeda A, Maeda K, Nagata T, Ueda K. Kamimura G, et al. Gen Thorac Cardiovasc Surg. 2024 May 28. doi: 10.1007/s11748-024-02042-w. Online ahead of print. Gen Thorac Cardiovasc Surg. 2024. PMID: 38805108

5

Giant Cell Tumor of Soft Tissue: An Updated Review.

Nishio J, Nakayama S, Koga K, Aoki M. Nishio J, et al. J Clin Med. 2024 May 13;13(10):2870. doi: 10.3390/jcm13102870. J Clin Med. 2024. PMID: 38792412 Free PMC article. Review.

6

Keratin-Positive Giant Cell-Rich Tumor: A Review and Update.

Nishio J, Nakayama S, Koga K, Aoki M. Nishio J, et al. Cancers (Basel). 2024 May 20;16(10):1940. doi: 10.3390/cancers16101940. Cancers (Basel). 2024. PMID: 38792018 Free PMC article. Review.

7

Generality Assessment of a Model Considering Heterogeneous Cancer Cells for Predicting Tumor Control Probability for Stereotactic Body Radiation Therapy Against Non-Small Cell Lung Cancer.

Saga R, Matsuya Y, Obara H, Komai F, Yoshino H, Aoki M, Hosokawa Y. Saga R, et al. Adv Radiat Oncol. 2024 Jan 1;9(4):101437. doi: 10.1016/j.adro.2023.101437. eCollection 2024 Apr. Adv Radiat Oncol. 2024. PMID: 38778820 Free PMC article.

8

In vivo-stable bis-iminobiotin for targeted radionuclide delivery with the mutant streptavidin.

Tatsumi T, Zhao S, Kasahara A, Aoki M, Nishijima KI, Ukon N, Kodama T, Takahashi K, Sugiyama A, Washiyama K, Yamatsugu K, Kanai M. Tatsumi T, et al. Bioorg Med Chem Lett. 2024 May 21;108:129803. doi: 10.1016/j.bmcl.2024.129803. Online ahead of print. Bioorg Med Chem Lett. 2024. PMID: 38777280

9

[Sporadic Inclusion Body Myositis].

Aoki M, Izumi R, Suzuki N. Aoki M, et al. Brain Nerve. 2024 May;76(5):660-670. doi: 10.11477/mf.1416202657. Brain Nerve. 2024. PMID: 38741510 Review. Japanese.

10

C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study.

Morikawa T, Naiki T, Sugiyama Y, Naiki-Ito A, Nagai T, Etani T, Iida K, Isobe T, Noda Y, Shimizu N, Aoki M, Gonda M, Banno R, Kubota H, Ando R, Umemoto Y, Kawai N, Yasui T. Morikawa T, et al. Cancers (Basel). 2024 Apr 28;16(9):1725. doi: 10.3390/cancers16091725. Cancers (Basel). 2024. PMID: 38730675 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,578 results

Search Page